𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma

✍ Scribed by Hildebrandt, M A T; Gu, J; Lin, J; Ye, Y; Tan, W; Tamboli, P; Wood, C G; Wu, X


Book ID
109972483
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
299 KB
Volume
29
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Clinical factors associated with outcome
✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to